Refine by:
-
Letter to DEA Administrator and US Attorney General on Medication Access, Telehealth and COVID-19
Letter to Attorney General Garland and DEA Administrator Milgram, urging action to ensure patients are able to continue receiving treatment where and when they need it once the PHE ends and until the promulgation of the Special Registration for Telemedicine Rules. -
Letter to Biden Administration on Medicaid and COVID-19
Letter to CMS leadership, thanking CMS for issuing its recent guidance on Medicaid redeterminations and offering recommendations on further actions they should take. -
Letter to Congressional Committee Leadership on Medicaid Benefit for Vaccine Transportation
Letter to Congressional Committee Leadership, urging support for H.R. 3013, the “COVID Vaccine Transportation Access Act,” which would help support non-emergency medical transportation options to vaccine sites for Medicaid beneficiaries. -
Letter to Congressional Committee Leadership on COVID-19 & Medicare
Letter to Congressional Committee Leadership, urging support for H.R. 8020, the “Seniors Access to Vaccines Ensured (SAVE) Act” of 2021, which would create a temporary Medicare non-emergency medical transportation benefit during the public health emergency to transport seniors to and from COVID vaccination appointments. -
Letter to Congressional Leadership on COVID-19 & Medicaid
Letter to Congressional leadership, expressing support for the provision in the COVID relief reconciliation bill that will provide would provide additional funding for the direct care workforce within Medicaid Home and Community Based Services (HCBS). -
Letter to HHS Secretary on COVID-19 & Medicare
Letter to HHS Acting Secretary Cochran, urging to ensure all people with Medicare have accessible and affordable health care and prescription drug coverage, during the COVID-19 crisis and beyond. -
Letter to HHS Secretary on Medicare & COVID-19
Letter to the Health and Human Services Secretary requesting the immediate reinstatement of two critical COVID-19 related Medicare enrollment flexibilities: the Special Enrollment Period for Part C and Part D2 and Equitable Relief for Premium Part A and Part B
